Literature DB >> 2872936

Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry.

J S Schneider, C H Markham.   

Abstract

N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces substantia nigra pars compacta (SNc) cell death in several species including the mouse, dog and monkey. MPTP is presently shown to cause apparent nigral cell death in the SNc of the cat as noted by a long-lasting decrease in tyrosine-hydroxylase (TH)-like cell staining. A transient loss of TH-like staining is also observed in the ventral tegmental area, locus coeruleus and retrorubral area. These latter areas appear normal 1.5-5.0 months after MPTP administration. The caudate nucleus (CD) showed a greater TH depletion than the nucleus accumbens (ACC) and only recovered slightly over time. After 7 days of MPTP, an apparent axonopathy, characterized by lightly staining fibers with large TH-positive varicosities, is seen in the CD and to a lesser extent, in the ACC. These findings demonstrate that MPTP is toxic to the cat's nigrostriatal dopaminergic system and suggests that the cat is a good intermediate species in which to study the responses of dopaminergic neurons to MPTP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872936     DOI: 10.1016/0006-8993(86)90340-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons.

Authors:  D J Doudet; C Gross; M Arluison; B Bioulac
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

2.  Selective decrease of immunoreactive tyrosine hydroxylase in nigrostriatum of adult male rats after N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.

Authors:  L L Vacca-Galloway; R Ikeda; S Y Coleman
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

3.  Transplacental effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on brain dopaminergic neurons in the mouse. An immunohistochemical study.

Authors:  S Furune; K Miura; K Watanabe; S Nagao; H Takahashi; M Sakai; M Spatz; I Nagatsu
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Administration of FGF-1 through transfected cells alleviates MPTP toxicity in mice.

Authors:  R N McLay; S M Freeman; J E Zadina
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

5.  Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.

Authors:  Y Muramatsu; R Kurosaki; T Mikami; M Michimata; M Matsubara; Y Imai; H Kato; Y Itoyama; T Araki
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

6.  Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).

Authors:  E Koutsilieri; W W Chan; D Reinitzer; W D Rausch
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences.

Authors:  Rebecca Banerjee; Sen Sreetama; Karuppagounder S Saravanan; Sailendra Nath Dey; Kochupurackal P Mohanakumar
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.